Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Cells. 2024 Sep 26;13(19):1614. doi: 10.3390/cells13191614.
Human coronaviruses (HCoVs) modify host proteins to evade the antiviral defense and sustain viral expansion. Here, we report tonicity-responsive enhancer (TonE) binding protein (TonEBP) as a cellular target of HCoVs. TonEBP was cleaved into N-terminal and C-terminal fragments (TonEBP NT and TonEBP CT, respectively) by NSP5 from all the HCoVs tested. This cleavage resulted in the loss of TonEBP's ability to stimulate the TonE-driven transcription. On the other hand, TonEBP NT promoted viral expansion in association with the suppression of expression. TonEBP NT competed away NF-κB binding to the PRD II domain on the promoter. A TonEBP mutant resistant to the cleavage by NSP5 did not promote the viral expansion nor suppress the expression. These results demonstrate that HCoVs use a common strategy of targeting TonEBP to suppress the host immune defense.
人类冠状病毒(HCoVs)修饰宿主蛋白以逃避抗病毒防御并维持病毒的扩张。在这里,我们报告渗透压反应增强子(TonE)结合蛋白(TonEBP)作为 HCoVs 的细胞靶标。NSP5 从所有测试的 HCoVs 中切割 TonEBP 成 N 端和 C 端片段(分别为 TonEBP NT 和 TonEBP CT)。这种切割导致 TonEBP 刺激 TonE 驱动转录的能力丧失。另一方面,TonEBP NT 促进了病毒的扩张,同时抑制了 的表达。TonEBP NT 与 NF-κB 竞争结合到 启动子上的 PRD II 结构域。一种对 NSP5 的切割具有抗性的 TonEBP 突变体既不能促进病毒的扩张,也不能抑制 的表达。这些结果表明,HCoVs 使用靶向 TonEBP 的共同策略来抑制宿主的免疫防御。